Directorio

We are doing this study to find out how well an experimental drug called DSP-5336 (the study drug) works in people with AML or ALL.

We have created this repository as a way for people to let us know they are interested in being contacted about future research studies. These studies will aim to improve the health and wellbeing of people by using mobile technology or other interventions. If you would like more information please contact us at dbhtl@duke.edu

Our Duke Vaccine and Trials Unit Volunteer Registry is a way for people to let our team know that you are interested in learning more about any of our vaccine studies you may be interested in. For more information or to sign up, visit us at: https://redcap.duke.edu/redcap/surveys/?s=WC8MR9PLMN Nuestro Registro Voluntario de la Unidad de Vacunas y Ensayos Clínicos de Duke es el medio a través del cual las personas pueden hacerle saber a nuestro equipo que están interesados en conocer más sobre nuestros estudios de investigación en los cuales podrían participar. Para más información o para registrarse, visítenos en: https://redcap.duke.edu/redcap/surveys/?s=WC8MR9PLMN

Our Duke Health and Exercise Research Trials Registry is a way for people to let our team know that they are interested in learning more about any of our studies for which they may qualify. Our studies include both healthy people and those who may have certain medical conditions.

We created the Duke Clinical Research Volunteer Registry for people who would like to join clinical research studies. We will use this registry to contact you about available studies. For more information or to sign up, visit us at: https://redcap.duke.edu/redcap/surveys/?s=X4T7JKHPX4

A registry is a database of information (data) about patients living with a specific condition. Scientists study the information in the registry to increase what we know about the condition so we can develop better treatments in the future. This registry will help us better understand lupus and how it is managed, including how different treatments work and their long-term safety.

We are doing this study to look at components of the blood to see if there are features that distinguish people with dystonia from people without dystonia. Identifying "biomarkers" in the blood that are associated with dystonia is greatly needed to help more accurately diagnosis dystonia and to identify subsets of dystonias that may have shared mechanisms. Being able to group individuals by underlying mechanisms can guide people with dystonia to the most appropriate future treatments that act specifically to correct one cause or another.

We are doing this study to find out if infusing chemotherapy drugs directly into the hepatic artery (the blood vessel that supplies blood to the liver) is a better treatment option than standard chemotherapy for people who have colorectal cancer that has spread to the liver.